移植后早期转换为贝拉塔塞普:技术现状和专家意见
Johan Noble1,2, Dany Anglicheau3, Gilles Blancho4,5
1Néphrologie, hémodialyse, aphérèse et transplantation, CHU Grenoble Alpes, La Tronche, France
Nephrologie & therapeutique
|March 11, 2025
概括
早期转换为新型免疫抑制剂贝拉塔塞普,改善了移植的结果. 这种方法可以增强功能,但需要对急性排斥和感染进行监测.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 标准的移植后免疫抑制包括氨抑制剂,抗代谢物或mTOR抑制剂与皮质类固醇.
- 这些标准治疗带有毒性和其他副作用的风险.
- 贝拉塔塞普特通过阻断CD80/86共刺激提供了一个替代方案,显示出改善结果的希望.
研究的目的:
- 审查移植患者早期转换为贝拉塔塞普治疗的疗效和安全性研究.
- 评估早期贝拉塔塞普转换对功能和免疫学参数的影响.
- 识别与早期贝拉塔塞普转换相关的潜在风险,例如急性排斥和感染.
主要方法:
- 发表的临床试验和观察性研究的系统审查和摘要.
- 分析了 de novo belatacept 和早期转换研究 (移植后6个月内) 的数据.
- 评估功能参数,捐赠者特异性抗体的发生率,急性细胞排斥率和机会性感染.
主要成果:
- 与标准免疫抑制相比,早期转换为贝拉塔塞普显著改善功能.
- 贝拉塔塞普特治疗与降低了供体特异性抗体的发生率有关.
- 急性细胞排斥和机会性感染的增加需要仔细监测.
结论:
- 早期转换为贝拉是一种可行的策略,可以增强功能,减少移植患者的抗体形成.
- 虽然有效,但仔细的患者选择和对排斥和感染的警监测对于成功的贝拉塔塞普特治疗至关重要.
- 贝拉塔塞普特代表了器官移植免疫抑制策略的重大进展.
相关概念视频
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...